Stable Istotope Labelled Ozoralizumab Biosimilar – Anti-ALB/TNFSF2/TNF-alpha/TNFA mAb – Research Grade

Reference: PX-TA1272-SIL-1MG
Product nameStable Istotope Labelled Ozoralizumab Biosimilar - Anti-ALB/TNFSF2/TNF-alpha/TNFA mAb - Research Grade
SourceCAS 1167985-17-2
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsATN-103
ReferencePX-TA1272-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeVH-VH'-VH
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-ALB/TNFSF2/TNF-alpha/TNFA [Homo sapiens] (Ozoralizumab) Monoclonal Antibody

Ozoralizumab has been investigated for the treatment of Rheumatoid Arthritis.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Ozoralizumab Biosimilar – Anti-ALB/TNFSF2/TNF-alpha/TNFA mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below